Approvals· August 27, 2026 · 18 min read
Tivicay PD's Neonatal Expansion: Term, 2 kg Floor; Tablets Do Not Substitute
By Ran Chen#FDA Approval#HIV#Infectious Disease
Topic
HIV
HIV treatment access, long-acting therapy, formulary coverage, patient support, and payer restrictions.
Approvals· August 12, 2026 · 34 min read
Gilead's BIC/LEN Single-Tablet HIV Regimen: PDUFA, Phase 3, and Access
By Ran Chen#FDA Approval#HIV#Gilead Sciences
Pricing & Access· July 11, 2026 · 16 min read
GSK Portfolio Dossier: ViiV HIV, Nucala Runway, and Oncology Rebuild
By Ran Chen#HIV#Respiratory#Infectious Disease
Evidence· July 4, 2026 · 17 min read
HIV antiretrovirals in FAERS: 205,550 adverse-event reports by the numbers
By Ran Chen#HIV#Real-World Evidence#Label Warnings
Pricing & Access· May 29, 2026 · 10 min read
Idvynso HIV access guide: PA criteria, switching, and affordability
By Ran Chen#HIV#Infectious Disease#Prior Authorization